{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:07:05Z","timestamp":1790816825270,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360063"],"award-info":[{"award-number":["82360063"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007935","name":"Hainan Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007935","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013142","name":"Key Research and Development Project of Hainan Province","doi-asserted-by":"publisher","award":["ZDYF2022SHFZ070"],"award-info":[{"award-number":["ZDYF2022SHFZ070"]}],"id":[{"id":"10.13039\/501100013142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["822QN480"],"award-info":[{"award-number":["822QN480"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["821RC1127"],"award-info":[{"award-number":["821RC1127"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.taap.2026.118001","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T15:00:33Z","timestamp":1786978833000},"page":"118001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Inhibition of Calpain-1 ameliorates doxorubicin-induced cardiotoxicity by suppression of p53-mediated ferroptosis"],"prefix":"10.1016","volume":"516","author":[{"given":"Zhuo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinbin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dabao","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengya","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junru","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaowu","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maozhong","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuewu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.taap.2026.118001_bb0005","doi-asserted-by":"crossref","DOI":"10.3390\/toxics13040277","article-title":"Pathophysiology of doxorubicin-mediated cardiotoxicity","volume":"13","author":"Arrigoni","year":"2025","journal-title":"Toxics"},{"key":"10.1016\/j.taap.2026.118001_bb0010","article-title":"Protosappanin a protects DOX-induced myocardial injury and cardiac dysfunction by targeting ACSL4\/FTH1 axis-dependent ferroptosis","volume":"11","author":"Cui","year":"2024","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.taap.2026.118001_bb0015","doi-asserted-by":"crossref","first-page":"199","DOI":"10.4103\/ijmr.IJMR_879_20","article-title":"Cardiac morbidity & mortality in patients with breast cancer: a review","volume":"154","author":"Dhir","year":"2021","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.taap.2026.118001_bb0020","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","article-title":"Acyl-CoA synthase ACSL4: an essential target in ferroptosis and fatty acid metabolism","volume":"136","author":"Ding","year":"2023","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.taap.2026.118001_bb0025","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.118001_bb0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1097\/00000421-198212000-00015","article-title":"Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathy","volume":"5","author":"Dresdale","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"key":"10.1016\/j.taap.2026.118001_bb0035","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1073\/pnas.1821022116","article-title":"Ferroptosis as a target for protection against cardiomyopathy","volume":"116","author":"Fang","year":"2019","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.taap.2026.118001_bb0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41569-022-00735-4","article-title":"The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease","volume":"20","author":"Fang","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.taap.2026.118001_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/nu15102259","article-title":"p53 at the crossroads between doxorubicin-induced cardiotoxicity and resistance: a nutritional balancing act","volume":"15","author":"Guo","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.taap.2026.118001_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1497733","article-title":"Calycosin alleviates ferroptosis and attenuates doxorubicin-induced myocardial injury via the Nrf2\/SLC7A11\/GPX4 signaling pathway","volume":"15","author":"Han","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.103024","article-title":"Pharmacological activation of GPX4 ameliorates doxorubicin-induced cardiomyopathy","volume":"70","author":"Huang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2026.118001_bb0060","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.taap.2026.118001_bb0065","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.freeradbiomed.2024.08.001","article-title":"MG53 inhibits ferroptosis by targeting the p53\/SLC7A11\/GPX4 pathway to alleviate doxorubicin-induced cardiotoxicity","volume":"223","author":"Jiang","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2026.118001_bb0070","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1594419","article-title":"ACSL4 at the helm of the lipid peroxidation ship: a deep-sea exploration towards ferroptosis","volume":"16","author":"Jiang","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0075","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.freeradbiomed.2018.05.074","article-title":"The tumor suppressor protein p53 and the ferroptosis network","volume":"133","author":"Kang","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.taap.2026.118001_bb0080","doi-asserted-by":"crossref","first-page":"760","DOI":"10.7150\/ijbs.65258","article-title":"Underlying the mechanisms of doxorubicin-induced acute cardiotoxicity: oxidative stress and cell death","volume":"18","author":"Kong","year":"2022","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.taap.2026.118001_bb0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1128\/MCB.17.1.460","article-title":"Proteolytic cleavage of human p53 by calpain: a potential regulator of protein stability","volume":"17","author":"Kubbutat","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2026.118001_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1586937","article-title":"Ophiopogonin D mitigates doxorubicin-induced cardiomyocyte ferroptosis through the \u03b2-catenin\/GPX4 pathway","volume":"16","author":"Lei","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0095","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00726-020-02824-5","article-title":"Taurine prevents cardiomyocyte apoptosis by inhibiting the calpain-1\/cytochrome c pathway during RVH in broilers","volume":"52","author":"Li","year":"2020","journal-title":"Amino Acids"},{"key":"10.1016\/j.taap.2026.118001_bb0100","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41598-021-03947-9","article-title":"Calpain-mediated protein targets in cardiac mitochondria following ischemia-reperfusion","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.taap.2026.118001_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2022.110008","article-title":"Exploring the role of ferroptosis in the doxorubicin-induced chronic cardiotoxicity using a murine model","volume":"363","author":"Li","year":"2022","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.taap.2026.118001_bb0110","article-title":"SLC7A11\/GPX4 inactivation-mediated ferroptosis contributes to the pathogenesis of triptolide-induced cardiotoxicity","volume":"2022","author":"Liu","year":"2022","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.taap.2026.118001_bb0115","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s00395-022-00948-1","article-title":"Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis","volume":"117","author":"Liu","year":"2022","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.taap.2026.118001_bb0120","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1016\/j.ekir.2024.08.019","article-title":"TRPC6-Calpain-1 axis promotes tubulointerstitial inflammation by inhibiting mitophagy in diabetic kidney disease","volume":"9","author":"Liu","year":"2024","journal-title":"Kidney Int. Rep."},{"key":"10.1016\/j.taap.2026.118001_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2026.157861","article-title":"American ginseng-derived extracellular vesicle-like nanoparticles (AGELNs) mitigate doxorubicin-induced cardiotoxicity by inhibiting GPX4-mediated ferroptosis","volume":"152","author":"Liu","year":"2026","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.118001_bb0130","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.taap.2026.118001_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2023.101205","article-title":"Doxorubicin and other anthracyclines in cancers: activity, chemoresistance and its overcoming","volume":"93","author":"Mattioli","year":"2023","journal-title":"Mol. Asp. Med."},{"key":"10.1016\/j.taap.2026.118001_bb0140","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1007\/s00018-020-03694-6","article-title":"The regulatory roles of p53 in cardiovascular health and disease","volume":"78","author":"Men","year":"2021","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.taap.2026.118001_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118074","article-title":"Sodium thiosulfate prevents doxorubicin-induced DNA damage and apoptosis in cardiomyocytes in mice","volume":"257","author":"Mizuta","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.taap.2026.118001_bb0150","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1142\/S0192415X25500454","article-title":"Astragaloside IV improves pulmonary vascular endothelial dysfunction in pulmonary arterial hypertension by inhibiting ferroptosis through modulation of the Calpain-1\/TGF-\u03b2\/TFRC pathway","volume":"53","author":"Niu","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.taap.2026.118001_bb0155","article-title":"The imbalance of p53-Park7 signaling axis induces iron homeostasis dysfunction in doxorubicin-challenged cardiomyocytes","volume":"10","author":"Pan","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.taap.2026.118001_bb0160","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1128\/MCB.17.5.2806","article-title":"Proteolysis by calpains: a possible contribution to degradation of p53","volume":"17","author":"Pariat","year":"1997","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.taap.2026.118001_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.670479","article-title":"Analysis of models of doxorubicin-induced cardiomyopathy in rats and mice. A modern view from the perspective of the pathophysiologist and the clinician","volume":"12","author":"Podyacheva","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0170","doi-asserted-by":"crossref","first-page":"26031","DOI":"10.1074\/jbc.M302833200","article-title":"Calpains mediate p53 activation and neuronal death evoked by DNA damage","volume":"278","author":"Sedarous","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.taap.2026.118001_bb0175","doi-asserted-by":"crossref","first-page":"4931","DOI":"10.7150\/thno.108410","article-title":"AIG1 protects against doxorubicin-induced cardiomyocyte ferroptosis and cardiotoxicity by promoting ubiquitination-mediated p53 degradation","volume":"15","author":"Shi","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.taap.2026.118001_bb0180","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.taap.2026.118001_bb0185","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrc3050","article-title":"The calpain system and cancer","volume":"11","author":"Storr","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.taap.2026.118001_bb0190","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/cncr.11407","article-title":"Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials","volume":"97","author":"Swain","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.taap.2026.118001_bb0195","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/CIRCRESAHA.119.314681","article-title":"Mitochondrial determinants of doxorubicin-induced cardiomyopathy","volume":"126","author":"Wallace","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.taap.2026.118001_bb0200","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/cvr\/cvt048","article-title":"Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin","volume":"98","author":"Wang","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.taap.2026.118001_bb0205","doi-asserted-by":"crossref","first-page":"809","DOI":"10.7150\/ijms.94485","article-title":"Role of mitochondria in doxorubicin-mediated cardiotoxicity: from molecular mechanisms to therapeutic strategies","volume":"21","author":"Wang","year":"2024","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.taap.2026.118001_bb0210","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1016\/j.ajpath.2024.09.004","article-title":"Calpain-1 up-regulation promotes bleomycin-induced pulmonary fibrosis by activating ferroptosis","volume":"194","author":"Wei","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.taap.2026.118001_bb0215","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.tips.2022.10.003","article-title":"Mitochondrial quality control mechanisms as therapeutic targets in doxorubicin-induced cardiotoxicity","volume":"44","author":"Wu","year":"2023","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.taap.2026.118001_bb0220","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1097\/CM9.0000000000003758","article-title":"GSTP1-mediated inhibition of ACSL4-dependent ferroptosis via JNK pathway in DOX-induced cardiomyopathy","volume":"138","author":"Wu","year":"2025","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.taap.2026.118001_bb0225","doi-asserted-by":"crossref","DOI":"10.3390\/antiox14080930","article-title":"CIRBP stabilizes Slc7a11 mRNA to sustain the SLC7A11\/GPX4 antioxidant axis and limit ferroptosis in doxorubicin-induced cardiotoxicity","volume":"14","author":"Xie","year":"2025","journal-title":"Antioxidants"},{"key":"10.1016\/j.taap.2026.118001_bb0230","article-title":"Xin-Ji-Er-Kang improves MIR injury-induced heart failure via the Calpain1\/Bid signaling pathway","volume":"360","author":"Xu","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0235","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1124\/mol.108.053546","article-title":"Enhancement of doxorubicin cytotoxicity on human esophageal squamous cell carcinoma cells by indomethacin and 4-[5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide (SC236) via inhibiting P-glycoprotein activity","volume":"75","author":"Yu","year":"2009","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.taap.2026.118001_bb0240","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.bbrc.2016.08.124","article-title":"Identification of ACSL4 as a biomarker and contributor of ferroptosis","volume":"478","author":"Yuan","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.taap.2026.118001_bb0245","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/nm.2919","article-title":"Identification of the molecular basis of doxorubicin-induced cardiotoxicity","volume":"18","author":"Zhang","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.taap.2026.118001_bb0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112423","article-title":"The molecular mechanisms of ferroptosis and its role in cardiovascular disease","volume":"145","author":"Zhang","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.taap.2026.118001_bb0255","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103066","article-title":"Hydrogen sulfide protects cardiomyocytes from doxorubicin-induced ferroptosis through the SLC7A11\/GSH\/GPx4 pathway by Keap1 S-sulfhydration and Nrf2 activation","volume":"70","author":"Zhang","year":"2024","journal-title":"Redox Biol."},{"key":"10.1016\/j.taap.2026.118001_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155250","article-title":"Astragaloside IV mitigates hypoxia-induced cardiac hypertrophy through calpain-1-mediated mTOR activation","volume":"125","author":"Zhang","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.taap.2026.118001_bb0265","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1093\/eurheartj\/ehaf374","article-title":"Ferroptosis in cardiovascular disease: regulatory mechanisms and therapeutic implications","volume":"46","author":"Zhao","year":"2025","journal-title":"Eur. Heart J."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X26002978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:46:05Z","timestamp":1790815565000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X26002978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":53,"alternative-id":["S0041008X26002978"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2026.118001","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of Calpain-1 ameliorates doxorubicin-induced cardiotoxicity by suppression of p53-mediated ferroptosis","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2026.118001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"118001"}}